CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Figure 3.Relationship between CDK16 level and OS. (A) The univariate Cox regression OS analysis of CDK16 in TCGA pan-cancer. Red color represents significant results (p < 0.05). (B–G) Kaplan-Meier curves showing OS in pan-cancer.